Carcinoid & Neuroendocrine Tumor Society

An association of patients, caregivers and physicians, promoting better understanding of carcinoid and neuroendocrine cancer,
a relatively rare disease which is poorly understood and is often misdiagnosed.

CNETS Singapore Welcomes You
Welcome to the website of Carcinoid & Neuroendocrine Tumor Society. This website is operated by CNETS Singapore, and is intended to serve the Asia Pacific community of patients, family caregivers and physicians.

Carcinoid and neuroendocrine disease is a rare cancer affecting less than 5 in 100,000 persons. Although the carcinoid community in every locality is small, patients in USA, Canada and Europe are served by a variety of support groups and public foundations. Some groups have regular monthly meetings and there are national conventions at least once per year. But in most Asia Pacific countries, including Australia, there are no support groups for neuroendocrine patients. And patients living in these countries rarely have a chance to meetup.

Asian Region

Now there is a support group in Asia Pacific for carcinoid and neuroendocrine tumor patients, family caregivers, researchers and physicians. The group is known as Carcinoid and Neuroendocrine Tumor Society (CNETS) and is headquartered in Singapore - the little red dot in the map shown at right.

We take our name from the Carcinoid-NeuroEndocrine Tumour Society Canada, with which we have established ties. The founders of both groups hope that CNETS can expand to serve other regions through a loose affiliation of non-profit charities, enabled by the Internet.

The primary focus of the CNETS Singapore organisation is to establish an online resource which spans Asia Pacific borders to provide 24 x 7 support for the carcinoid community. Our current online resources include a complete library of video recordings from carcinoid & neuroendocrine medical conferences. A wiki is planned, to tap the experience of patients, caregivers and physicians throughout the region.



News Highlights
Passing of Dr Shahid Mahmood Singapore, 1 Jan 2010 - The internationally renowned nuclear medicine specialist Dr Shahid Mahmood of Singapore has passed away unexpectedly. Many NETs patients will have met Dr Shahid if they visited his office at RadLink Diagnostic Imaging to receive Ga-68 PET/CET scans. Dr. Shahid's company established Singapore's first Ga-68 PET/CET scan in February 2009, and in March 2009 the company launched a cyclotron to produce radioisotopes for imaging. He collaborated with other organisations to promote Singapore as a centre of excellence in NETs treatment too. Although he was in private medical practice, Dr Shahid had a keen commitment to academic work, and was an active member of the Nuclear Medicine Specialist Training Committee, and Vice President of the Academy of Medicine, Chapter of Nuclear Medicine Physicians. His passing is a great loss to the nuclear medicine community here.
Novartis Launches NET Alliance Novartis Oncology has announced an initiative to improve patient outcomes by advancing awareness and management of NETs. The initiative is intended as a longterm partnership with patient groups, physicians and clinical staff.
Selected Current News